-Vyvo Smart Chain (VSC), a HealthFi ecosystem that leverages Web3 technology to promote positive lifestyle habits, today announced the listing of its native utility coin, $VSC, on premier cryptocurrency exchange, MEXC.
Everly Health, a digital health company at the forefront of remote diagnostics-driven care, today announced the launch of a comprehensive at-home collection kidney health test for health plans and employers to expand access to prevention, diagnosis, and treatment of chronic kidney disease (CKD).
CharmHealth, a leading provider of healthcare technology solutions, today announced three breakthroughs to improve patient care.
-Altera Digital Health, a global health IT leader, and Harris Affinity (Affinity), a leading provider of financial decision support tools, today announced their new reseller agreement.
Amwell® , a leader in hybrid health care enablement, today announced a collaboration with Nestlé Health Science, a global leader in the science of nutrition, to help health organizations improve patients’ overall health through innovative digital solutions focused on nutrition.
Welldoc®, a digital health leader revolutionizing chronic care, today announced the expansion of its platform to support weight management.
V2 Communications (V2), an integrated communications firm for innovative technology brands in the B2B, healthcare, and climate sectors, has forged partnerships with Exo, Health Gorilla, and Neura Health, deepening its foothold in the healthcare technology market.
Butterfly Network, Inc. a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, and Razom, a US-based nonprofit dedicated to supporting a democratic and prosperous Ukraine, today announced that they have expanded their global health partnership to bring an additional 200 Butterfly iQ+ devices to the frontlines of the war in Ukraine.
Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, today announced that it has raised $35 million in Series B funding, led by Kurma Partners’ Growth Opportunities Fund, with participation from existing investors Seroba Life Sciences and Irish, U.S. and Canadian based family offices and Enterprise Ireland.
ELMC Rx Solutions, LLC (“ELMCRx”) is pleased to announce its independent launch. This follows its purchase by Principal Owner and CEO, Richard Fleder, from its former parent, ELMC Risk Solutions, LLC (“ELMC”).